Hypoxia Inducible Factor 1 Alpha Inhibitor Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1281488 No. of Pages: 77 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Hypoxia Inducible Factor 1 Alpha Inhibitor in global, including the following market information:
Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Hypoxia Inducible Factor 1 Alpha Inhibitor companies in 2021 (%)
The global Hypoxia Inducible Factor 1 Alpha Inhibitor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
BC-001 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hypoxia Inducible Factor 1 Alpha Inhibitor include Aileron Therapeutics, Inc., CASI Pharmaceuticals Inc., Cerulean Pharma, Inc., F. Hoffmann-La Roche Ltd., InterMed Discovery GmbH, OncoImmune, Inc., Peloton Therapeutics, Inc., RXi Pharmaceuticals Corporation and Sorrento Therapeutics, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hypoxia Inducible Factor 1 Alpha Inhibitor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Segment Percentages, by Type, 2021 (%)
BC-001
CASI-2ME2
CRLX-101
Others
Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Segment Percentages, by Application, 2021 (%)
Solid Tumor
Acute Myelocytic Leukemia
Colorectal Cancer
Others
Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hypoxia Inducible Factor 1 Alpha Inhibitor revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hypoxia Inducible Factor 1 Alpha Inhibitor revenues share in global market, 2021 (%)
Key companies Hypoxia Inducible Factor 1 Alpha Inhibitor sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Hypoxia Inducible Factor 1 Alpha Inhibitor sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aileron Therapeutics, Inc.
CASI Pharmaceuticals Inc.
Cerulean Pharma, Inc.
F. Hoffmann-La Roche Ltd.
InterMed Discovery GmbH
OncoImmune, Inc.
Peloton Therapeutics, Inc.
RXi Pharmaceuticals Corporation
Sorrento Therapeutics, Inc.
Transcriptogen Ltd
Vascular Biogenics Ltd.
1 Introduction to Research & Analysis Reports
1.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Overall Market Size
2.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size: 2021 VS 2028
2.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales: 2017-2028
3 Company Landscape
3.1 Top Hypoxia Inducible Factor 1 Alpha Inhibitor Players in Global Market
3.2 Top Global Hypoxia Inducible Factor 1 Alpha Inhibitor Companies Ranked by Revenue
3.3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Companies
3.4 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Companies
3.5 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Hypoxia Inducible Factor 1 Alpha Inhibitor Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Hypoxia Inducible Factor 1 Alpha Inhibitor Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hypoxia Inducible Factor 1 Alpha Inhibitor Players in Global Market
3.8.1 List of Global Tier 1 Hypoxia Inducible Factor 1 Alpha Inhibitor Companies
3.8.2 List of Global Tier 2 and Tier 3 Hypoxia Inducible Factor 1 Alpha Inhibitor Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Markets, 2021 & 2028
4.1.2 BC-001
4.1.3 CASI-2ME2
4.1.4 CRLX-101
4.1.5 Others
4.2 By Type - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue & Forecasts
4.2.1 By Type - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue, 2017-2022
4.2.2 By Type - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue, 2023-2028
4.2.3 By Type - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share, 2017-2028
4.3 By Type - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales & Forecasts
4.3.1 By Type - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, 2017-2022
4.3.2 By Type - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, 2023-2028
4.3.3 By Type - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share, 2017-2028
4.4 By Type - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2021 & 2028
5.1.2 Solid Tumor
5.1.3 Acute Myelocytic Leukemia
5.1.4 Colorectal Cancer
5.1.5 Others
5.2 By Application - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue & Forecasts
5.2.1 By Application - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue, 2017-2022
5.2.2 By Application - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue, 2023-2028
5.2.3 By Application - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share, 2017-2028
5.3 By Application - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales & Forecasts
5.3.1 By Application - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, 2017-2022
5.3.2 By Application - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, 2023-2028
5.3.3 By Application - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share, 2017-2028
5.4 By Application - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2021 & 2028
6.2 By Region - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue & Forecasts
6.2.1 By Region - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue, 2017-2022
6.2.2 By Region - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue, 2023-2028
6.2.3 By Region - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share, 2017-2028
6.3 By Region - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales & Forecasts
6.3.1 By Region - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, 2017-2022
6.3.2 By Region - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, 2023-2028
6.3.3 By Region - Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue, 2017-2028
6.4.2 By Country - North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, 2017-2028
6.4.3 US Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.4.4 Canada Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.4.5 Mexico Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue, 2017-2028
6.5.2 By Country - Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, 2017-2028
6.5.3 Germany Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.5.4 France Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.5.5 U.K. Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.5.6 Italy Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.5.7 Russia Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.5.8 Nordic Countries Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.5.9 Benelux Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue, 2017-2028
6.6.2 By Region - Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, 2017-2028
6.6.3 China Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.6.4 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.6.5 South Korea Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.6.6 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.6.7 India Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue, 2017-2028
6.7.2 By Country - South America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, 2017-2028
6.7.3 Brazil Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.7.4 Argentina Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, 2017-2028
6.8.3 Turkey Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.8.4 Israel Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.8.5 Saudi Arabia Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
6.8.6 UAE Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Aileron Therapeutics, Inc.
7.1.1 Aileron Therapeutics, Inc. Corporate Summary
7.1.2 Aileron Therapeutics, Inc. Business Overview
7.1.3 Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Major Product Offerings
7.1.4 Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Revenue in Global (2017-2022)
7.1.5 Aileron Therapeutics, Inc. Key News
7.2 CASI Pharmaceuticals Inc.
7.2.1 CASI Pharmaceuticals Inc. Corporate Summary
7.2.2 CASI Pharmaceuticals Inc. Business Overview
7.2.3 CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Major Product Offerings
7.2.4 CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Revenue in Global (2017-2022)
7.2.5 CASI Pharmaceuticals Inc. Key News
7.3 Cerulean Pharma, Inc.
7.3.1 Cerulean Pharma, Inc. Corporate Summary
7.3.2 Cerulean Pharma, Inc. Business Overview
7.3.3 Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Major Product Offerings
7.3.4 Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Revenue in Global (2017-2022)
7.3.5 Cerulean Pharma, Inc. Key News
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.4.2 F. Hoffmann-La Roche Ltd. Business Overview
7.4.3 F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Major Product Offerings
7.4.4 F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Revenue in Global (2017-2022)
7.4.5 F. Hoffmann-La Roche Ltd. Key News
7.5 InterMed Discovery GmbH
7.5.1 InterMed Discovery GmbH Corporate Summary
7.5.2 InterMed Discovery GmbH Business Overview
7.5.3 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Major Product Offerings
7.5.4 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Revenue in Global (2017-2022)
7.5.5 InterMed Discovery GmbH Key News
7.6 OncoImmune, Inc.
7.6.1 OncoImmune, Inc. Corporate Summary
7.6.2 OncoImmune, Inc. Business Overview
7.6.3 OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Major Product Offerings
7.6.4 OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Revenue in Global (2017-2022)
7.6.5 OncoImmune, Inc. Key News
7.7 Peloton Therapeutics, Inc.
7.7.1 Peloton Therapeutics, Inc. Corporate Summary
7.7.2 Peloton Therapeutics, Inc. Business Overview
7.7.3 Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Major Product Offerings
7.7.4 Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Revenue in Global (2017-2022)
7.7.5 Peloton Therapeutics, Inc. Key News
7.8 RXi Pharmaceuticals Corporation
7.8.1 RXi Pharmaceuticals Corporation Corporate Summary
7.8.2 RXi Pharmaceuticals Corporation Business Overview
7.8.3 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Major Product Offerings
7.8.4 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Revenue in Global (2017-2022)
7.8.5 RXi Pharmaceuticals Corporation Key News
7.9 Sorrento Therapeutics, Inc.
7.9.1 Sorrento Therapeutics, Inc. Corporate Summary
7.9.2 Sorrento Therapeutics, Inc. Business Overview
7.9.3 Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Major Product Offerings
7.9.4 Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Revenue in Global (2017-2022)
7.9.5 Sorrento Therapeutics, Inc. Key News
7.10 Transcriptogen Ltd
7.10.1 Transcriptogen Ltd Corporate Summary
7.10.2 Transcriptogen Ltd Business Overview
7.10.3 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Major Product Offerings
7.10.4 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Revenue in Global (2017-2022)
7.10.5 Transcriptogen Ltd Key News
7.11 Vascular Biogenics Ltd.
7.11.1 Vascular Biogenics Ltd. Corporate Summary
7.11.2 Vascular Biogenics Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Business Overview
7.11.3 Vascular Biogenics Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Major Product Offerings
7.11.4 Vascular Biogenics Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Revenue in Global (2017-2022)
7.11.5 Vascular Biogenics Ltd. Key News
8 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Capacity, Analysis
8.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Capacity, 2017-2028
8.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Production Capacity of Key Manufacturers in Global Market
8.3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hypoxia Inducible Factor 1 Alpha Inhibitor Supply Chain Analysis
10.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Industry Value Chain
10.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Upstream Market
10.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com